Because regardless of price it is currently too risky to buy now without FDA approvals. If things do not go to plan with Tali milestones and approvals Akili can wash their hands of Tali at very minimal cost to them.
A small portion of the $50mill best case scenario for Tali.
To buy Tali now, Akili would need to stump up $50mill and then go through the approvals phase with risk of failure ontop of the $50mill purchase. That itself would cost more than $50mill for a lemon.
They are getting Tali FDA approved for less $ and risk as what it would cost if they owned it.
There will be a moment when they see that Tali is the real deal and will compliment them and pounce.
- Forums
- ASX - By Stock
- Ann: TALi Product Clinical & International Update & 4C
Because regardless of price it is currently too risky to buy now...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TD1 (ASX) to my watchlist
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.295M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $54 | 53.61K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 23619429 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 35609707 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 23619429 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 34609707 | 15 |
0.003 | 37370277 | 11 |
0.004 | 1185025 | 2 |
0.005 | 4000000 | 1 |
0.006 | 250000 | 1 |
Last trade - 14.52pm 23/08/2024 (20 minute delay) ? |
Featured News
TD1 (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online